| Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis M Tintoré, A Rovira, MJ Martínez, J Rio, P Díaz-Villoslada, L Brieva, ... American Journal of Neuroradiology 21 (4), 702-706, 2000 | 598 | 2000 |
| Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? M Tintoré, A Rovira, J Rio, C Tur, R Pelayo, C Nos, N Téllez, H Perkal, ... Neurology 70 (13 Part 2), 1079-1083, 2008 | 383 | 2008 |
| Defining the response to interferon‐β in relapsing‐remitting multiple sclerosis patients J Río, C Nos, M Tintoré, N Téllez, I Galán, R Pelayo, M Comabella, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 353 | 2006 |
| Defining high, medium and low impact prognostic factors for developing multiple sclerosis M Tintore, À Rovira, J Río, S Otero-Romero, G Arrambide, C Tur, ... Brain 138 (7), 1863-1874, 2015 | 341 | 2015 |
| Baseline MRI predicts future attacks and disability in clinically isolated syndromes M Tintoré, A Rovira, J Rio, C Nos, E Grivé, N Téllez, R Pelayo, ... Neurology 67 (6), 968-972, 2006 | 332 | 2006 |
| New diagnostic criteria for multiple sclerosis: application in first demyelinating episode M Tintore, A Rovira, J Rio, C Nos, E Grive, J Sastre-Garriga, I Pericot, ... Neurology 60 (1), 27-30, 2003 | 321 | 2003 |
| Diffusion-weighted MR imaging in the acute phase of transient ischemic attacks A Rovira, A Rovira-Gols, S Pedraza, E Grivé, C Molina, J Alvarez-Sabín American journal of neuroradiology 23 (1), 77-83, 2002 | 312* | 2002 |
| Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? N Téllez, J Río, M Tintoré, C Nos, I Galán, X Montalban Multiple Sclerosis Journal 11 (2), 198-202, 2005 | 269 | 2005 |
| Scoring treatment response in patients with relapsing multiple sclerosis MP Sormani, J Rio, M Tintore, A Signori, D Li, P Cornelisse, B Stubinski, ... Multiple Sclerosis Journal 19 (5), 605-612, 2013 | 244 | 2013 |
| Factors related with treatment adherence to interferon b and glatiramer acetate therapy in multiple sclerosis J Río, J Porcel, N Téllez, A Sánchez-Betancourt, M Tintoré, MJ Arévalo, ... Multiple Sclerosis Journal 11 (3), 306-309, 2005 | 238 | 2005 |
| Measures in the first year of therapy predict the response to interferon β in MS J Rio, J Castilló, A Rovira, M Tintore, J Sastre-Garriga, A Horga, C Nos, ... Multiple Sclerosis Journal 15 (7), 848-853, 2009 | 235 | 2009 |
| A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis M Comabella, JD Lünemann, J Rio, A Sanchez, C Lopez, E Julia, ... Brain 132 (12), 3353-3365, 2009 | 214 | 2009 |
| Transcription-based prediction of response to IFNβ using supervised computational methods SE Baranzini, P Mousavi, J Rio, SJ Caillier, A Stillman, P Villoslada, ... PLoS Biol 3 (1), e2, 2004 | 210 | 2004 |
| Plasma osteopontin levels in multiple sclerosis M Comabella, I Pericot, R Goertsches, C Nos, M Castillo, JB Navarro, ... Journal of neuroimmunology 158 (1-2), 231-239, 2005 | 174 | 2005 |
| Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6 months S Llufriu, J Castillo, Y Blanco, L Ramio-Torrenta, J Rio, M Valles, ... Neurology 73 (12), 949-953, 2009 | 171 | 2009 |
| Brainstem lesions in clinically isolated syndromes M Tintore, A Rovira, G Arrambide, R Mitjana, J Rio, C Auger, C Nos, ... Neurology 75 (21), 1933-1938, 2010 | 163 | 2010 |
| Assessment of different treatment failure criteria in a cohort of relapsing–remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials J Río, C Nos, M Tintoré, C Borrás, I Galán, M Comabella, X Montalban Annals of Neurology: Official Journal of the American Neurological …, 2002 | 152 | 2002 |
| Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients J Rio, A Rovira, M Tintoré, E Huerga, C Nos, N Tellez, C Tur, ... Multiple Sclerosis Journal 14 (4), 479-484, 2008 | 148 | 2008 |
| Is optic neuritis more benign than other first attacks in multiple sclerosis? M Tintoré, A Rovira, J Rio, C Nos, E Grivé, N Téllez, R Pelayo, ... Annals of neurology 57 (2), 210-215, 2005 | 146 | 2005 |
| Genome-wide scan of 500 000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis M Comabella, DW Craig, C Morcillo-Suárez, J Río, A Navarro, ... Archives of neurology 66 (8), 972-978, 2009 | 132 | 2009 |
